September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...
Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. (NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with ...
DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or ...
Compared with limited fasciectomy for Dupuytren contracture, injections of the enzyme collagenase are less costly but also less effective at straightening fingers. Nonetheless, patients may prefer the ...
Hosted on MSN
Dupuytren's Contracture: Is Surgery Right for Me?
If you have Dupuytren's contracture, you're likely familiar with the many nonsurgical ways to manage the condition, including hand exercises, physical therapy, and injections. While these treatments ...
Treatment options for Dupuytren’s contracture include limited fasciectomy and collagenase injection, but data comparing the two approaches are lacking. New research findings are summarized in a short ...
MALVERN, Pa., Feb. 17, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its new branded television commercial, Steve's Journey. The campaign, featuring a real Dupuytren's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results